These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38591855)

  • 1. Osteosarcoma cell death induced by innovative scaffolds doped with chemotherapeutics.
    Lanzillotti C; Iaquinta MR; De Pace R; Mosaico M; Patergnani S; Giorgi C; Tavoni M; Dapporto M; Sprio S; Tampieri A; Montesi M; Martini F; Mazzoni E
    J Cell Physiol; 2024 May; 239(5):e31256. PubMed ID: 38591855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D modular bioceramic scaffolds for the investigation of the interaction between osteosarcoma cells and MSCs.
    Hao J; Yu X; Tang K; Ma X; Lu H; Wu C
    Acta Biomater; 2024 Aug; 184():431-443. PubMed ID: 38897335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
    Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
    Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A novel tissue-engineered bone constructed by using human adipose-derived stem cells and biomimetic calcium phosphate scaffold coprecipitated with bone morphogenetic protein-2].
    Jiang WR; Zhang X; Liu YS; Wu G; Ge YJ; Zhou YS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Feb; 49(1):6-15. PubMed ID: 28202997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strontium(II) and mechanical loading additively augment bone formation in calcium phosphate scaffolds.
    Reitmaier S; Kovtun A; Schuelke J; Kanter B; Lemm M; Hoess A; Heinemann S; Nies B; Ignatius A
    J Orthop Res; 2018 Jan; 36(1):106-117. PubMed ID: 28574614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium phosphate-phosphorylated adenosine hybrid microspheres for anti-osteosarcoma drug delivery and osteogenic differentiation.
    Zhou ZF; Sun TW; Chen F; Zuo DQ; Wang HS; Hua YQ; Cai ZD; Tan J
    Biomaterials; 2017 Mar; 121():1-14. PubMed ID: 28063979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic Mesoporous Calcium Sillicate/Chitosan Porous Scaffolds for Enhanced Bone Regeneration and Photothermal-Chemotherapy of Osteosarcoma.
    Yang F; Lu J; Ke Q; Peng X; Guo Y; Xie X
    Sci Rep; 2018 May; 8(1):7345. PubMed ID: 29743489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strontium substitution in apatitic CaP cements effectively attenuates osteoclastic resorption but does not inhibit osteoclastogenesis.
    Schumacher M; Wagner AS; Kokesch-Himmelreich J; Bernhardt A; Rohnke M; Wenisch S; Gelinsky M
    Acta Biomater; 2016 Jun; 37():184-94. PubMed ID: 27084107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in osteogenic sarcoma cells by combination of tumor necrosis factor-related apoptosis inducing ligand and chemotherapeutic agents.
    Sun J; Fu ZM; Fang CQ; Li JH
    Chin Med J (Engl); 2007 Mar; 120(5):400-4. PubMed ID: 17376311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma.
    Li W; Zhang X; Xi X; Li Y; Quan H; Liu S; Wu L; Wu P; Lan W; Shao Y; Li H; Chen K; Hu Z
    Cancer Med; 2020 Jun; 9(12):4371-4385. PubMed ID: 32349184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal short-chain C6 ceramide induces potent anti-osteosarcoma activity in vitro and in vivo.
    Zhai L; Sun N; Han Z; Jin HC; Zhang B
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):274-80. PubMed ID: 26505795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression.
    Zhou Y; Zhao RH; Tseng KF; Li KP; Lu ZG; Liu Y; Han K; Gan ZH; Lin SC; Hu HY; Min DL
    Acta Pharmacol Sin; 2016 Apr; 37(4):519-29. PubMed ID: 26924291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
    Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
    Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LY294002 suppresses the malignant phenotype and sensitizes osteosarcoma cells to pirarubicin chemotherapy.
    Long XH; Zhong ZH; Peng AF; Zhu LB; Wang H; Zhang GM; Liu ZL
    Mol Med Rep; 2014 Dec; 10(6):2967-72. PubMed ID: 25310590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-Sequential and Multi-Functional 3D Printed MgO
    Li C; Zhang W; Nie Y; Du X; Huang C; Li L; Long J; Wang X; Tong W; Qin L; Lai Y
    Adv Mater; 2024 Aug; 36(34):e2308875. PubMed ID: 38091500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinational delivery of anticancer drugs for osteosarcoma treatment using electrosprayed core shell nanocarriers.
    Prasad SR; Jayakrishnan A; Kumar TSS
    J Mater Sci Mater Med; 2020 May; 31(5):44. PubMed ID: 32367204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics.
    Engert F; Kovac M; Baumhoer D; Nathrath M; Fulda S
    Oncotarget; 2017 Jul; 8(30):48794-48806. PubMed ID: 27447864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a doxorubicin-loaded bioinspired bone cement for the localized treatment of osteosarcoma.
    Martinez T; Sarda S; Dupret-Bories A; Charvillat C; Projetti F; Drouet C
    Future Oncol; 2021 Sep; 17(26):3511-3528. PubMed ID: 34213375
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
    Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
    Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC inhibitor-loaded bone cement for advanced local treatment of osteosarcoma and chondrosarcoma.
    Tonak M; Becker M; Graf C; Eckhard L; Theobald M; Rommens PM; Wehler TC; Proschek D
    Anticancer Res; 2014 Nov; 34(11):6459-66. PubMed ID: 25368246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.